Journal article icon

Journal article

Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
Journal:
JOURNAL OF THORACIC ONCOLOGY More from this journal
Volume:
4
Issue:
9
Pages:
S413-S413
Publication date:
2009-09-01
ISSN:
1556-0864
Pubs id:
pubs:236670
UUID:
uuid:fda22a27-621e-4e19-b689-0a2a595b58c5
Local pid:
pubs:236670
Source identifiers:
236670
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP